Citius Oncology, Inc. CTOR Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Citius Oncology, Inc.'s other income (expense)?
- Citius Oncology, Inc. (CTOR) reported other income (expense) of $1.77M in Q1 2026.
- How has Citius Oncology, Inc.'s other income (expense) changed year-over-year?
- Citius Oncology, Inc.'s other income (expense) increased by 4003.3% year-over-year, from -$45.41K to $1.77M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.